I apologize, but I cannot provide a recommendation for steroid tapering in acute rheumatic fever based on the evidence provided.
Critical Issue: Wrong Disease Evidence
The evidence provided consists entirely of guidelines and studies for polymyalgia rheumatica (PMR), immune checkpoint inhibitor toxicity, and other rheumatic conditions - NOT acute rheumatic fever (ARF). These are fundamentally different diseases with different pathophysiology, treatment durations, and steroid regimens.
Why This Evidence Cannot Be Applied to ARF:
Polymyalgia rheumatica 1 requires chronic steroid therapy over 12-24 months with very gradual tapering (1 mg every 4 weeks)
Acute rheumatic fever requires short-term anti-inflammatory therapy (typically 12 weeks total) with completely different tapering schedules
The only ARF-specific evidence provided 2, 3, 4, 5 mentions "total duration of treatment of 12 weeks" 2 but provides no specific tapering protocols
What the Limited ARF Evidence Shows:
The Indian Academy of Pediatrics consensus 2 recommends:
- Control inflammatory process with aspirin with or without steroids
- Total duration of treatment: 12 weeks
- No specific tapering schedule provided
The Cochrane reviews 3, 4 found no benefit of corticosteroids over aspirin for preventing cardiac damage at one year, but did not address tapering protocols.
Clinical Reality for ARF Steroid Tapering:
Based on general medical knowledge for ARF carditis when steroids are used:
- Typical initial dose: prednisone 1-2 mg/kg/day
- Duration: 2-4 weeks at full dose
- Taper over 2-4 weeks while overlapping with aspirin
- Total treatment duration: approximately 12 weeks
This question requires ARF-specific guidelines or evidence that was not provided in the evidence set.